Tiopronin Tablet, Delayed Release
Product Images NDC 60219-2009

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tiopronin (NDC 60219-2009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Tiopronin Delayed Release Tablets 300 mg 1)

Chemical structure of the active ingredient tiopronin, depicted with molecular groups including a thiol (SH), carbonyl (C=O), and carboxylic acid (COOH) functional groups.*

FDA Label Image

1 (Tiopronin Delayed Release Tablets 300 mg 2)

Label for Tiopronin Delayed-Release Tablets 300 mg by Amneal Pharmaceuticals NY LLC. The label indicates 90 tablets per package, with each delayed-release tablet containing 300 mg of tiopronin. It displays a tablet imprint "L6" and storage instructions specifying room temperature. Manufactured in India and distributed in the U.S.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.